Your Location：
Home >
Browse articles >
Qinlian Hongqutang Improves NASH by Promoting Macrophage Polarization Through TLR4 and STAT6 Signaling Pathways
Updated：2026-03-19
Previous|Next

    • Qinlian Hongqutang Improves NASH by Promoting Macrophage Polarization Through TLR4 and STAT6 Signaling Pathways

      Enhanced Publication
    • “Research has found that Qinlian Hongqu decoction can effectively improve liver inflammation in mice with non-alcoholic fatty liver disease, and its mechanism may drive M1 macrophages to polarize towards M2 through the STAT6 and TLR4 signaling pathways.”
    • ZHANG Yong , HU Yong , HE Yunliang , YANG Yang , CHEN Donghui , DANG Sijie , HE Jia , LUO Yaqi
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 8, Pages: 10-20(2026)

    • DOI： 10.13422/j.cnki.syfjx.20252205     

      CLC：

    • Revised：2025-10-12 ，

      Accepted：20 October 2025 ，

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 8 ) Tabs( 8 )

  • References

  • Publication Info

  • Metrics

409

Views

301

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Effect of Yinqi Sanhuang Jiedu Decoction on Piezo1-YAP Signaling Axis and Macrophage Polarization in Mouse Model of Liver Fibrosis
Mechanisms of Celastrus orbiculatus Ethylacetate Extract in Regulating M2 Macrophage Polarization to Inhibit Gastric Cancer Proliferation and Migration
Shaoyaotang Regulates miRNA-155-mediated SOCS1/JAK1/STAT1 Signaling Pathway to Affect Macrophage Polarization
Regulatory Mechanisms and Strategies of Traditional Chinese Medicine Intervention in Diabetic Atherosclerosis Based on Macrophage Autophagy： A Review
Astragali Radix Polysaccharides Promote M2 Polarization of OGD/R-induced BV2 Microglia by Inhibiting TLR4/NF-κB Signaling Pathway

Related Author

LEI Chao
LI Yanbo
ZHANG Houyan
QIAO Meng
WU Qingjuan
LYU Wenliang
WANG Zhifei
LI Dan

Related Institution

Guang'anmen Hospital， China Academy of Chinese Medical Sciences
Postdoctoral Research Station，China Academy of Chinese Medical Sciences
Institute of Basic Research in Clinical Medicine， China Academy of Chinese Medical Sciences
Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State Administration of Traditional Chinese Medicine， Medical College， Yangzhou University/Yangzhou Cancer Research Institute
Department of Physiology， School of Medicine， Showa University